Tuesday, September 22, 2026

The recent jump in US borrowing costs is driving a fresh wave of net investment hedging (NIH), as corporates seek to capitalise on favourable interest rate differentials by protecting the value of their foreign assets and locking in carry gains.

NIH serves to shield the reported value of foreign assets from currency fluctuations within accounting statements. For US companies, hedging investments in countries with higher interest rates has traditionally come at a premium.

However, with the US Federal Reserve continuing to raise overnight rates, the cost-benefit calculus is shifting, prompting increased adoption of NIH strategies across the corporate sector.

Source link

Exit mobile version